The E-Prescribing Market To See An Influx Of Big Data In The Healthcare Cloud

According to a new market report published by Persistence Market Research "Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019," the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.

Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. The global E-Prescribing market is witnessing a significant growth led by various government programs to implement E-Prescribing systems in order to improve quality of healthcare and reduce medication errors.

Strategizing The Moves For The Next Decade? See Through Sample Of E Prescribing Market Report! https://www.persistencemarketresearch.co/samples/3087

Some of the major players operating in the E-Prescribing market:

Henry Schein, Inc.
Cerner Corporation.
Allscripts.
eClinicalWorks.
DrFirst.
Practice Fusion, Inc.
Surescripts.
HealthFusion, Inc.
Emdeon.
athenahealth, Inc.
Starting With The New Decade On A Diligent Note In The E Prescribing Market? https://www.persistencemarketresearch.co/methodology/3087

E-Prescribing systems are used in various applications including preparation of complete medication list, data security checks, complete information of formulary and patient historical data. These advanced features of E-Prescribing are also supporting in growth of E-Prescribing market. Additionally, improved healthcare infrastructure has increased the demand for E-Prescribing system.

Moreover, implementation of electronic healthcare records with E-Prescribing system holds immense potential for the growth of E-Prescribing market. E-Prescribing market is expected to grow a CAGR of about 23.5% during 2013-2019.

However, high cost of E-Prescribing system and lack of patient privacy and security impede growth of E-Prescribing market. Moreover, lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the E-Prescribing market.

Europe holds the largest share in E-Prescribing market. Many eHealth projects in Europe are playing a vital role in the adoption of E-Prescribing system such as European Patient Smart Open Services (epSOS) and Schleswig-Holstein Health Initiative.

How About Obtaining Insights About The Region To Enter Concerning The E Prescribing Market? Press The "Purchase Now" Button To Have Our E Prescribing Market Report! https://www.persistencemarketresearch.com/checkout/3087

However, North America is the fastest growing region in the E-Prescribing market. Increased adoption of E-Prescribing system and improved healthcare infrastructure are major drivers for E-Prescribing market in North America. Moreover, several government initiatives are also promoting the usage of E-Prescribing system such as Health Information Technology for Economic and Clinical Health (HITECH) Act and National Council for Prescription Drugs Program.

In Asia, usage of E-Prescribing system is increasing due to medical infrastructure development and government initiative programs. Growing medical infrastructure has led to improvement in primary healthcare services, village clinics and urban healthcare centers through the adoption of healthcare IT technologies.

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.